Ruiz Camps, I., & Aguilar-Company, J. (2021). Risk of infection associated with targeted therapies for solid organ and hematological malignancies.
Citación estilo ChicagoRuiz Camps, Isabel, y Juan Aguilar-Company. Risk of Infection Associated With Targeted Therapies for Solid Organ and Hematological Malignancies. 2021.
Cita MLARuiz Camps, Isabel, y Juan Aguilar-Company. Risk of Infection Associated With Targeted Therapies for Solid Organ and Hematological Malignancies. 2021.
Precaución: Estas citas no son 100% exactas.